JPH04234884A - カルバペネム化合物 - Google Patents

カルバペネム化合物

Info

Publication number
JPH04234884A
JPH04234884A JP3099750A JP9975091A JPH04234884A JP H04234884 A JPH04234884 A JP H04234884A JP 3099750 A JP3099750 A JP 3099750A JP 9975091 A JP9975091 A JP 9975091A JP H04234884 A JPH04234884 A JP H04234884A
Authority
JP
Japan
Prior art keywords
group
piperazinyl
hydrogen
methyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3099750A
Other languages
English (en)
Japanese (ja)
Inventor
Scott Louis Dax
スコツト・ルイス・ダツクス
Dennis Dalton Keith
デニス・ドルトン・キース
Pamela Loreen Rossman
パメラ・ロリーン・ロスマン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPH04234884A publication Critical patent/JPH04234884A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/26—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 4
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP3099750A 1990-04-09 1991-04-05 カルバペネム化合物 Pending JPH04234884A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50613590A 1990-04-09 1990-04-09
US506135 1990-04-09

Publications (1)

Publication Number Publication Date
JPH04234884A true JPH04234884A (ja) 1992-08-24

Family

ID=24013339

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3099750A Pending JPH04234884A (ja) 1990-04-09 1991-04-05 カルバペネム化合物

Country Status (17)

Country Link
EP (1) EP0451764A1 (show.php)
JP (1) JPH04234884A (show.php)
AU (1) AU7420591A (show.php)
BR (1) BR9101418A (show.php)
CA (1) CA2039987A1 (show.php)
CS (1) CS94391A2 (show.php)
FI (1) FI911666A7 (show.php)
HU (1) HUT57769A (show.php)
IE (1) IE911161A1 (show.php)
IL (1) IL97797A0 (show.php)
MC (1) MC2262A1 (show.php)
MX (1) MX25231A (show.php)
NO (1) NO911357L (show.php)
PT (1) PT97287A (show.php)
TW (1) TW216420B (show.php)
YU (1) YU62991A (show.php)
ZA (1) ZA912279B (show.php)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
SG47533A1 (en) * 1990-04-18 1998-04-17 Procter & Gamble Pharma Antimicrobial quinolonyl lactams
EP0606336B1 (en) * 1991-10-01 1997-03-19 PROCTER & GAMBLE PHARMACEUTICALS, INC. Process for making antimicrobial quinolonyl lactams
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
DE4234330A1 (de) * 1992-10-12 1994-04-14 Bayer Ag Chinoloncarbonsäuren
ATE190972T1 (de) * 1994-08-02 2000-04-15 Procter & Gamble Verfahren zur herstellung von antimikrobiellen verbindungen
MX9700872A (es) * 1994-08-02 1997-05-31 Procter & Gamble Procedimiento para producir antimicrobianos de quinolonil-lactama y compuestos intermediarios novedosos.
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
EP0695753A1 (en) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem derivatives containing a bicyclic substituent, process for their preparation, and their use
ATE247086T1 (de) * 1997-01-21 2003-08-15 Merck & Co Inc Verfahren zur herstellung von zwischenprodukten des carbapenems
US5973142A (en) * 1997-01-21 1999-10-26 Yasuda; Nobuyoshi Process for synthesizing carbapenem intermediates
US6080854A (en) * 1997-08-25 2000-06-27 Merck & Co., Inc. Process for synthesizing carbapenem intermediates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1179675A (en) * 1981-01-30 1984-12-18 Erwin Gotschi 7-oxo-1-azabicyclo ¬3,2,0| heptene-2-derivatives
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
US4767762A (en) * 1985-12-23 1988-08-30 Abbott Laboratories Tricyclic quinoline and naphthyride antibacterials
EP0366193A3 (en) * 1988-10-24 1992-01-08 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial quinolonyl lactams
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
ES2148135T3 (es) * 1988-10-24 2000-10-16 Norwich Eaton Pharma Nuevos esteres antimicrobianos de quinolonil lactamas.

Also Published As

Publication number Publication date
MX25231A (es) 1993-10-01
CA2039987A1 (en) 1991-10-10
TW216420B (show.php) 1993-11-21
YU62991A (sh) 1994-04-05
HU911132D0 (en) 1991-10-28
AU7420591A (en) 1991-10-10
PT97287A (pt) 1992-01-31
BR9101418A (pt) 1991-11-26
FI911666A7 (fi) 1991-10-10
ZA912279B (en) 1992-02-26
HUT57769A (en) 1991-12-30
IE911161A1 (en) 1991-10-09
IL97797A0 (en) 1992-06-21
NO911357D0 (no) 1991-04-08
NO911357L (no) 1991-10-10
EP0451764A1 (en) 1991-10-16
MC2262A1 (fr) 1993-04-26
FI911666A0 (fi) 1991-04-08
CS94391A2 (en) 1991-11-12

Similar Documents

Publication Publication Date Title
JPH04234884A (ja) カルバペネム化合物
KR100239612B1 (ko) 항미생물성 락탐-퀴놀론을 함유하는 조성물
US5093328A (en) Beta-lactam compounds
KR100244992B1 (ko) 퀴놀론 5-(n-헤테로치환된 아미노) 항미생물제
US5180719A (en) Antimicrobial quinolonyl lactam esters
AU705818B2 (en) Process for making quinolone-containing and related antimicrobial compounds
JP2977212B2 (ja) 新規な抗微生物キノロニルラクタム
CA2001201C (en) Antimicrobial quinolonyl lactams esters
US5491139A (en) Antimicrobial quinolonyl lactams
JPH05502884A (ja) 新規３―置換セフェム化合物及びその製造方法
HUT67423A (en) Process for the production of antimicrobal compounds containing quinolone moiety and beta-lactam moiety
JPH0730083B2 (ja) アシル誘導体
US5162523A (en) Cephalosporin antibacterial compounds
US5434147A (en) Antimicrobial quinolonyl lactam esters
KR100292395B1 (ko) 페넴화합물
JPS59196895A (ja) ６−（ヒドロキシアルキル）−２−（ヘテロアリ−ルアルキルチオ）ペネム類、それらの製造方法およびそれらを含む医薬組成物
US5159077A (en) Penam antibacterial compounds
JPH0285255A (ja) キノロンカルボン酸誘導体またはその塩
JPH01104076A (ja) 新規なβ−ラクタム化合物
JP3004954B2 (ja) セファロスポリンピリジニウム誘導体
JPH08245623A (ja) 抗生化合物
JPH0413355B2 (show.php)
IL92091A (en) Quinolonyl lactam esters and pharmaceutical preparations containing them
HK1013984B (en) Novel antimicrobial quinolonyl lactam esters